Loading...

Home
ETF
ONC

ONC

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ONC News

BeOne's Drug Shows Durable Efficacy in Chronic Lymphocytic Leukemia

Jun 12 2026Newsfilter

BeOne Medicines Stock Shows Oversold Signal

Jun 11 2026NASDAQ.COM

BRUKINSA Shows Long-Term Efficacy in Patients Over 80

Jun 11 2026Newsfilter

BeOne Medicines Presents New Data at ASCO Meeting

Jun 01 2026Newsfilter

BeOne's Drug Shows New Breakthroughs in CLL Treatment

May 29 2026Newsfilter

TEVIMBRA and ZIIHERA Combination Therapy Significantly Improves Survival Rates

May 27 2026Newsfilter

BeOne Medicines to Participate in Goldman Sachs Healthcare Conference

May 26 2026Newsfilter

BeOne Medicines Showcases New Advances at ASCO

May 21 2026Newsfilter

BeOne Launches Soccer Campaign to Enhance Cancer Care

May 20 2026Newsfilter

BeOne's Drug Receives FDA Accelerated Approval

May 13 2026stocktwits

BeOne Medicines Receives FDA Accelerated Approval for Beqalzi

May 13 2026seekingalpha

FDA Grants Accelerated Approval for BEQALZI as New BCL2 Inhibitor

May 13 2026Newsfilter

BeOne Medicines AG Q1 2026 Earnings Call Highlights

May 06 2026seekingalpha

BeiGene Q1 2026 Earnings Exceed Expectations with Strong Revenue Growth

May 06 2026seekingalpha

Latest Wall Street Rating Updates

May 04 2026CNBC

TEVIMBRA and ZIIHERA Combination Therapy Significantly Improves Survival Rates

Apr 29 2026Newsfilter